Results
|
|
9481.
|
|
|
|
9482.
|
|
|
|
9483.
|
|
|
|
9484.
|
|
|
|
9485.
|
|
|
|
9486.
|
|
|
|
9487.
|
|
|
|
9488.
|
|
|
|
9489.
|
|
|
|
9490.
|
|
|
|
9491.
|
|
|
|
9492.
|
|
|
|
9493.
|
|
|
|
9494.
|
|
|
|
9495.
|
Phase II trial evaluating the efficacy and safety of the anti-CD20 monoclonal antibody obinutuzumab in patients with marginal zone lymphoma. [electronic resource] by
- Grunenberg, Alexander
- Kaiser, Lisa M
- Woelfle, Stephanie
- Schmelzle, Birgit
- Viardot, Andreas
- Möller, Peter
- Barth, Thomas Fe
- Muche, Rainer
- Dreyhaupt, Jens
- Buske, Christian
Producer: 20210127
In:
Future oncology (London, England) vol. 16
Availability: No items available.
|
|
|
9496.
|
|
|
|
9497.
|
|
|
|
9498.
|
|
|
|
9499.
|
|
|
|
9500.
|
|